“…(Liu et al, 2018) As a biomarker, GAS5 is related to the risk of gastric cancer, uterine cervical cancer, and prostate cancer, and is also a potential marker of sepsis inflammation. (Dong et al, 2020;Lin et al, 2019;Weng et al, 2020;Zhang et al, 2022b) Associated with miR-21 and miR-140 as potential markers of allergic rhinitis. (Song et al, 2021) As far as current studies are concerned, GAS5 is up-regulated in neurosystemic diseases and plays a proinflammatory role in neuroinflammation.…”